Related Experiment Video
Updated: May 25, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Thrombosis and acute coronary syndrome
Rosanna Abbate1, Gabriele Cioni, Ilaria Ricci
1Department of Medical and Surgical Critical Care, University of Florence - SOD Atherothrombotic Diseases, AOU Careggi, Florence, Italy.
Acute coronary syndromes (ACS) involve plaque rupture and blood clot formation. Understanding thrombosis and inflammation markers like tissue factor (TF) is key for identifying high-risk patients.
Area of Science:
- Cardiovascular Medicine
- Pathophysiology
- Thrombosis Research
Background:
- Acute coronary syndromes (ACS) are a major manifestation of coronary atherosclerosis.
- Plaque rupture triggers thrombosis via collagen and tissue factor (TF) exposure, activating platelets and fibrin formation.
- Endothelial dysfunction, inflammation, and coagulation are interconnected in ACS pathophysiology.
Purpose of the Study:
- To explore the critical role of thrombosis in acute coronary syndromes.
- To investigate the relationship between endothelial damage, inflammation, and coagulation in ACS.
- To highlight potential biomarkers for vascular event risk identification.
Main Methods:
- Review of the pathophysiology of atherosclerotic plaque rupture and thrombosis.
- Analysis of the interplay between endothelial dysfunction, inflammation, and coagulation.
- Examination of the role of platelets in atherothrombotic events.
Main Results:
- Thrombosis is central to ACS, driven by plaque rupture exposing procoagulant factors.
- Platelet activation and fibrin formation are critical downstream events.
- Thrombin generation and TF may serve as predictive markers for vascular events.
- Lipoprotein-associated phospholipase A2 (Lp-PLA2) links lipid metabolism and inflammation.
Conclusions:
- Thrombosis is a pivotal mechanism in acute coronary syndromes.
- Platelets are crucial in both plaque development and acute atherothrombotic events.
- Markers like thrombin generation and TF are valuable for risk stratification in ACS patients.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
